1
40
2
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://doi.org/10.1097/MPH.0000000000000024" target="_blank" rel="noreferrer">http://doi.org/10.1097/MPH.0000000000000024</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Acute pain relief after Mantram meditation in children with neuroblastoma undergoing anti-GD2 monoclonal antibody therapy
Publisher
An entity responsible for making the resource available
Journal Of Pediatric Hematology/oncology
Date
A point or period of time associated with an event in the lifecycle of the resource
2014
Subject
The topic of the resource
adolescent; Child; Female; Humans; Male; retrospective studies; Pain; Neuroblastoma; Antineoplastic Agents; Preschool; Meditation; Antibodies; Gangliosides; Monoclonal
Creator
An entity primarily responsible for making the resource
Ahmed M; Modak S; Sequeira S
Description
An account of the resource
Nonpharmacologic, mind-body interventions are used to reduce anxiety in pediatric patients. Anti-ganglioside GD2 monoclonal antibody (anti-GD2 MoAb 3F8) therapy is the standard of care for high-risk neuroblastoma and pain is its major side effect. We performed a retrospective analysis of children undergoing anti-GD2 MoAb 3F8 treatment who received guided meditation. Meditation involved concentrating on the repetition of rhythmic, melodic sounds purported to slow breathing and induce a relaxation response. A total of 71% patients completed a session at first (n=19) or second attempt (n=5). Patients received fewer analgesic doses to manage anti-GD2 MoAb 3F8-induced pain when participating in meditation (n=17, mean=-0.4 dose, P<0.01). Mantram meditation is a feasible outpatient intervention associated with reduced analgesic requirements.
2014-03
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1097/MPH.0000000000000024" target="_blank" rel="noreferrer">10.1097/MPH.0000000000000024</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
2014
Adolescent
Ahmed M
Antibodies
Antineoplastic Agents
Backlog
Child
Female
Gangliosides
Humans
Journal Article
Journal Of Pediatric Hematology/oncology
Male
Meditation
Modak S
Monoclonal
Neuroblastoma
Pain
Preschool
Retrospective Studies
Sequeira S
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://doi.org/10.1002/cncr.20846" target="_blank" rel="noreferrer">http://doi.org/10.1002/cncr.20846</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Five-day courses of irinotecan as palliative therapy for patients with neuroblastoma
Publisher
An entity responsible for making the resource available
Cancer
Date
A point or period of time associated with an event in the lifecycle of the resource
2005
Subject
The topic of the resource
U.S. Gov't; PedPal Lit; Non-U.S. Gov't Research Support; 15 patients had stable disease; 2 (n=3); 2 (n=9); 22 (n=1 patient); 3 (n=1); 4 (n=2(TRUNCATED); 4 (n=6); 7 (n=1 patient); 7 were not evaluable for response because of concurrent radiotherapy; Adolescent Adult Antineoplastic Agents; although they did not have progressive disease (PD) after receiving 1 (n=10); and 1 patient had a major response. Twenty-one patients had PD after 1 (n=3; and myelosuppressive effects were readily managed. Hospitalizations were limited to three patients with bacteremia. Twenty-three patients had a change in therapy; diarrheal; Intravenous Male Nervous System Neoplasms/drug therapy Neuroblastoma/drug therapyPalliative Care Quality of Life Research Support; or 24 (n=1) courses. The most common reasons for changing treatment were to intensify retrieval therapy or to pursue immunotherapy. Of those 23 patients; P.H.S. Retrospective Studies Treatment Outcome; Phytogenic/administration & dosage/adverse effects Camptothecin/administration & dosage/adverse effects/analogs & derivatives Child Child; Preschool Female Humans Infusions
Creator
An entity primarily responsible for making the resource
Kushner BH; Kramer K; Modak S; Cheung NK
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1002/cncr.20846" target="_blank" rel="noreferrer">10.1002/cncr.20846</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
Description
An account of the resource
2005
15 patients had stable disease
2 (n=3)
2 (n=9)
2005
22 (n=1 patient)
3 (n=1)
4 (n=2(TRUNCATED)
4 (n=6)
7 (n=1 patient)
7 were not evaluable for response because of concurrent radiotherapy
Adolescent Adult Antineoplastic Agents
although they did not have progressive disease (PD) after receiving 1 (n=10)
and 1 patient had a major response. Twenty-one patients had PD after 1 (n=3
and myelosuppressive effects were readily managed. Hospitalizations were limited to three patients with bacteremia. Twenty-three patients had a change in therapy
Backlog
Cancer
Cheung NK
diarrheal
Intravenous Male Nervous System Neoplasms/drug therapy Neuroblastoma/drug therapyPalliative Care Quality of Life Research Support
Journal Article
Kramer K
Kushner BH
Modak S
Non-U.S. Gov't Research Support
or 24 (n=1) courses. The most common reasons for changing treatment were to intensify retrieval therapy or to pursue immunotherapy. Of those 23 patients
P.H.S. Retrospective Studies Treatment Outcome
PedPal Lit
Phytogenic/administration & dosage/adverse effects Camptothecin/administration & dosage/adverse effects/analogs & derivatives Child Child
Preschool Female Humans Infusions
U.S. Gov't